- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02904187
Cerebral Activation and Bilateral Stimulation by Cochlear Implantation in Bilateral Deaf Adults
December 13, 2025 updated by: Hospices Civils de Lyon
The primary objective to this study is to describe bilateral auditory information processing in profoundly deaf patients with bilateral cochlear implants compared with normal hearing patients.
Assumption used is that due to the central consequences of bilateral deafness on binaural auditory information central processing, time between activation of the two cochlear implants is a decisive factor in bilateral implantation compared to unilateral implantation
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
43
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Lyon, France, 69437
- Département d'ORL, Hôpital Edouard Herriot
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion criteria for patients:
- profoundly deaf patients with bilateral cochlear implants
Exclusion criteria for patients:
- post-operative complications
- incomplete surgical insertion of one of the cochlear implant
- age under 18 years
- non-compliant patient
- pregnant woman or woman with no efficient contraception method
- informed consent not signed
- no health insurance
Inclusion criteria for control
- normal hearing subjects
Exclusion criteria control
- normal hearing subject
- subject under 18 years old
- unilateral or bilateral hearing loss
- non-compliant subject
- pregnant woman or woman with no efficient contraception method
- informed consent not signed
- no health insurance
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Profound deaf patients
Profound deaf patients with bilateral cochlear implants: Cortical brain activation pattern obtained by PET and EEG
|
|
|
Other: Healthy volunteers
Healthy volunteers: Cortical brain activation pattern obtained by PET and EEG
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cortical brain activation pattern
Time Frame: 6 months
|
Cortical brain activation pattern obtained by PET or EEG cartography.
Activation pattern will be compared between normal hearing subjects and deaf adults with bilateral cochlear implants
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 17, 2010
Primary Completion (Actual)
March 22, 2016
Study Completion (Actual)
March 22, 2016
Study Registration Dates
First Submitted
August 11, 2016
First Submitted That Met QC Criteria
September 13, 2016
First Posted (Estimated)
September 16, 2016
Study Record Updates
Last Update Posted (Estimated)
December 19, 2025
Last Update Submitted That Met QC Criteria
December 13, 2025
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Neurologic Manifestations
- Nervous System Diseases
- Otorhinolaryngologic Diseases
- Sensation Disorders
- Ear Diseases
- Hearing Loss
- Hearing Disorders
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Deafness
- Investigative Techniques
- Chemistry Techniques, Analytical
- Spectrum Analysis
- Magnetic Resonance Spectroscopy
Other Study ID Numbers
- 2008-542
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.